New Cardiovascular Horizons (NCVH) 2017

Medication Compliance: Motivating Providers and Patients to Do the Right Thing

By New Cardiovascular Horizons (NCVH) 2017
By New Cardiovascular Horizons (NCVH) 2017
6 views
September 19, 2017
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
31:10
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Feat. D. Berg
01:34
Gore Medical

To Close or Not to Close? PFO-Stroke Case Study of 20-Year-Old Female

Feat. J. Volpi
01:16
Gore Medical

Do PFO Characteristics Determine Recurrent Stroke Risk?

Feat. J. Volpi
28:45
ASPC 2020 Virtual Summit on CVD Prevention

Apolipoprotein B & CVD Risk: How Can We Improve CVD Prevention W…

Feat. A. Sniderman
01:41
Gore Medical

Latest PFO-stroke Study Data

01:44
Gore Medical

Is your stroke patient a candidate for PFO closure?

Feat. J. Volpi
07:20
Cardiometabolic Health Congress (CMHC)

Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, R…

Feat. K. Ferdinand
26:28
Cynthia Stuenkel

Management of Women with Complex Medical Conditions: Cardiovascular …

18:46
ASPC 2020 Virtual Summit on CVD Prevention

How Can We Prevent the Majority of CV Events? What Are the Milion He…

Feat. L. Sperling
16:05
ASPC 2020 Virtual Summit on CVD Prevention

Polypill for CVD Prevention: When Is Polypharmacy Appropriate? Can R…

Feat. K. Ferdinand
16:33
ASPC 2020 Virtual Summit on CVD Prevention

Menopause and Its Impact on Women's CVD Health: How to Assess R…

Feat. E. Michos
06:48
Cardiometabolic Health Congress (CMHC)

Cardiometabolic Medicine: What Are the Trends in Mortality, Risk &am…

Feat. K. Ferdinand
10:43
Houston Methodist DeBakey Heart and Vascular Center

Why and Who Needs to See a Preventive Cardiologist?

Feat. M. Shapiro
08:05
Complex Coronary Valvular and Vascular Cases Conference

Lymphedema: Treatment Options For Severe Lifestyle Limiting Lymphede…

28:02
ASPC 2020 Virtual Summit on CVD Prevention

CVD Prevention for Women: What Are the Unique/Predominant Risk Facto…

Feat. N. Wenger
05:34
Innovations in Cardiovascular Therapeutics 2016

Vascular medicine for the practicing cardiologist

Feat. T. Polonsky
17:21
Cardiology Fiesta 2017

Anti-Platelet Therapy

Feat. H. Ahmed
28:23
ASPC 2020 Virtual Summit on CVD Prevention

New Insights Into Assessing Risk for Hispanic Patients: Why it Is Im…

Feat. I. Pina
28:03
AVA at Your Fingertips

Examining the Case For Just In Case Vascular Access Discussion

Feat. J. A. Bell
30:04
AVA at Your Fingertips

How to Improve Vascular Access for Patients? What Are The Steps for …

Feat. J. A. Bell